Monitoring people’s blood pressure can effectively prevent blood pressure-related diseases. Therefore, providing a convenient and comfortable approach can effectively help patients in monitoring blood pressure. In this study, an attention mechanism-based convolutional long short-term memory (LSTM) neural network is proposed to easily estimate blood pressure. To easily and comfortably estimate blood pressure, electrocardiogram (ECG) and photoplethysmography (PPG) signals are acquired. To precisely represent the characteristics of ECG and PPG signals, the signals in the time and frequency domain are selected as the inputs of the proposed NN structure. To automatically extract the features, the convolutional neural networks (CNNs) are adopted as the first part of neural networks. To identify the meaningful features, the attention mechanism is used in the second part of neural networks. To model the characteristic of time series, the long short-term memory (LSTM) is adopted in the third part of neural networks. To integrate the information of previous neural networks, the fully connected networks are used to estimate blood pressure. The experimental results show that the proposed approach outperforms CNN and CNN-LSTM and complies with the Association for the Advancement of Medical Instrumentation standard.

A novel aptamer-based competitive drug screening platform for osteoporosis was devised in which fluorescence-labeled, sclerostin-specific aptamers compete with compounds from selected chemical libraries for the binding of immobilized recombinant human sclerostin to achieve high-throughput screening for potential small-molecule sclerostin inhibitors and to facilitate drug repurposing and drug discovery. Of the 96 selected inhibitors and FDA-approved drugs, six were shown to result in a significant decrease in the fluorescence intensity of the aptamer, suggesting a higher affinity toward sclerostin compared with that of the aptamer. The targets of these potential sclerostin inhibitors were correlated to lipid or bone metabolism, and several of the compounds have already been shown to be potential osteogenic activators, indicating that the aptamer-based competitive drug screening assay offered a potentially reliable strategy for the discovery of target-specific new drugs. The six potential sclerostin inhibitors suppressed the level of both intracellular and/or extracellular sclerostin in mouse osteocyte IDG-SW3 and increased alkaline phosphatase activity in IDG-SW3 cells, human bone marrow-derived mesenchymal stem cells and human fetal osteoblasts hFOB1.19. Potential small-molecule drug candidates obtained in this study are expected to provide new therapeutics for osteoporosis as well as insights into the structure–activity relationship of sclerostin inhibitors for rational drug design.

Cardiovascular disease (CVD) is one of the leading causes of death globally. Currently, clinical diagnosis of CVD primarily relies on electrocardiograms (ECG), which are relatively easier to identify compared to other diagnostic methods. However, ensuring the accuracy of ECG readings requires specialized training for healthcare professionals. Therefore, developing a CVD diagnostic system based on ECGs can provide preliminary diagnostic results, effectively reducing the workload of healthcare staff and enhancing the accuracy of CVD diagnosis. In this study, a deep neural network with a cross-stage partial network and a cross-attention-based transformer is used to develop an ECG-based CVD decision system. To accurately represent the characteristics of ECG, the cross-stage partial network is employed to extract embedding features. This network can effectively capture and leverage partial information from different stages, enhancing the feature extraction process. To effectively distill the embedding features, a cross-attention-based transformer model, known for its robust scalability that enables it to process data sequences with different lengths and complexities, is employed to extract meaningful embedding features, resulting in more accurate outcomes. The experimental results showed that the challenge scoring metric of the proposed approach is 0.6112, which outperforms others. Therefore, the proposed ECG-based CVD decision system is useful for clinical diagnosis.

Amyotrophic lateral sclerosis (ALS) causes people to have difficulty communicating with others or devices. In this paper, multi-task learning with denoising and classification tasks is used to develop a robust steady-state visual evoked potential-based brain–computer interface (SSVEP-based BCI), which can help people communicate with others. To ease the operation of the input interface, a single channel-based SSVEP-based BCI is selected. To increase the practicality of SSVEP-based BCI, multi-task learning is adopted to develop the neural network-based intelligent system, which can suppress the noise components and obtain a high level of accuracy of classification. Thus, denoising and classification tasks are selected in multi-task learning. The experimental results show that the proposed multi-task learning can effectively integrate the advantages of denoising and discriminative characteristics and outperform other approaches. Therefore, multi-task learning with denoising and classification tasks is very suitable for developing an SSVEP-based BCI for practical applications. In the future, an augmentative and alternative communication interface can be implemented and examined for helping people with ALS communicate with others in their daily lives.